Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults
- Autores
- Martín Saborido, Carlos; López Alcalde, Jesús; Ciapponi, Agustín; Sánchez Martín, Carlos Enrique; Garcia Garcia, Elena; Escobar Aguilar, Gema; Palermo, Maria Carolina; Baccaro, Fernando G
- Año de publicación
- 2019
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: Among people who have suffered a traumatic brain injury, increased intracranial pressure continues to be a major cause of early death; it is estimated that about 11 people per 100 with traumatic brain injury die. Indomethacin (also known as indometacin) is a powerful cerebral vasoconstrictor that can reduce intracranial pressure and, ultimately, restore cerebral perfusion and oxygenation. Thus, indomethacin may improve the recovery of a person with traumatic brain injury. Objectives: To assess the effects of indomethacin for adults with severe traumatic brain injury. Search methods: We ran the searches from inception to 23 August 2019. We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 8) in the Cochrane Library, Ovid MEDLINE, Ovid Embase, CINAHL Plus (EBSCO), four other databases, and clinical trials registries. We also screened reference lists and conference abstracts, and contacted experts in the field. Selection criteria: Our search criteria included randomised controlled trials (RCTs) that compared indomethacin with any control in adults presenting with severe traumatic brain injury associated with elevated intracranial pressure, with no previous decompressive surgery. Data collection and analysis: Two review authors independently decided on the selection of the studies. We followed standard Cochrane methods. Main results: We identified no eligible studies for this review, either completed or ongoing. Authors' conclusions: We found no studies, either completed or ongoing, that assessed the effects of indomethacin in controlling intracranial hypertension secondary to severe traumatic brain injury. Thus, we cannot draw any conclusions about the effects of indomethacin on intracranial pressure, mortality rates, quality of life, disability or adverse effects. This absence of evidence should not be interpreted as evidence of no effect for indomethacin in controlling intracranial hypertension secondary to severe traumatic brain injury. It means that we have not identified eligible research for this review.
Fil: Martín Saborido, Carlos. Universidad Nebrija; España
Fil: López Alcalde, Jesús. No especifíca;
Fil: Ciapponi, Agustín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
Fil: Sánchez Martín, Carlos Enrique. No especifíca;
Fil: Garcia Garcia, Elena. Gobierno de la Provincia de Buenos Aires. Hospital Interzonal Especializado de Agudos y Cronicos San Juan de Dios.; Argentina
Fil: Escobar Aguilar, Gema. Universidad Nebrija; España
Fil: Palermo, Maria Carolina. Universidad de Buenos Aires; Argentina
Fil: Baccaro, Fernando G. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina - Materia
- hypertension
- Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/148149
Ver los metadatos del registro completo
id |
CONICETDig_c7cdcd6482c25f66da3cb8e461d1b114 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/148149 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adultsMartín Saborido, CarlosLópez Alcalde, JesúsCiapponi, AgustínSánchez Martín, Carlos EnriqueGarcia Garcia, ElenaEscobar Aguilar, GemaPalermo, Maria CarolinaBaccaro, Fernando Ghypertensionhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Background: Among people who have suffered a traumatic brain injury, increased intracranial pressure continues to be a major cause of early death; it is estimated that about 11 people per 100 with traumatic brain injury die. Indomethacin (also known as indometacin) is a powerful cerebral vasoconstrictor that can reduce intracranial pressure and, ultimately, restore cerebral perfusion and oxygenation. Thus, indomethacin may improve the recovery of a person with traumatic brain injury. Objectives: To assess the effects of indomethacin for adults with severe traumatic brain injury. Search methods: We ran the searches from inception to 23 August 2019. We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 8) in the Cochrane Library, Ovid MEDLINE, Ovid Embase, CINAHL Plus (EBSCO), four other databases, and clinical trials registries. We also screened reference lists and conference abstracts, and contacted experts in the field. Selection criteria: Our search criteria included randomised controlled trials (RCTs) that compared indomethacin with any control in adults presenting with severe traumatic brain injury associated with elevated intracranial pressure, with no previous decompressive surgery. Data collection and analysis: Two review authors independently decided on the selection of the studies. We followed standard Cochrane methods. Main results: We identified no eligible studies for this review, either completed or ongoing. Authors' conclusions: We found no studies, either completed or ongoing, that assessed the effects of indomethacin in controlling intracranial hypertension secondary to severe traumatic brain injury. Thus, we cannot draw any conclusions about the effects of indomethacin on intracranial pressure, mortality rates, quality of life, disability or adverse effects. This absence of evidence should not be interpreted as evidence of no effect for indomethacin in controlling intracranial hypertension secondary to severe traumatic brain injury. It means that we have not identified eligible research for this review.Fil: Martín Saborido, Carlos. Universidad Nebrija; EspañaFil: López Alcalde, Jesús. No especifíca;Fil: Ciapponi, Agustín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; ArgentinaFil: Sánchez Martín, Carlos Enrique. No especifíca;Fil: Garcia Garcia, Elena. Gobierno de la Provincia de Buenos Aires. Hospital Interzonal Especializado de Agudos y Cronicos San Juan de Dios.; ArgentinaFil: Escobar Aguilar, Gema. Universidad Nebrija; EspañaFil: Palermo, Maria Carolina. Universidad de Buenos Aires; ArgentinaFil: Baccaro, Fernando G. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; ArgentinaJohn Wiley & Sons Ltd2019-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/148149Martín Saborido, Carlos; López Alcalde, Jesús; Ciapponi, Agustín; Sánchez Martín, Carlos Enrique; Garcia Garcia, Elena; et al.; Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults; John Wiley & Sons Ltd; Cochrane Database of Systematic Reviews; 2019; 11; 11-2019; 1-251469-493XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://doi.wiley.com/10.1002/14651858.CD011725.pub2info:eu-repo/semantics/altIdentifier/doi/10.1002/14651858.CD011725.pub2info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:02:18Zoai:ri.conicet.gov.ar:11336/148149instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:02:18.885CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults |
title |
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults |
spellingShingle |
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults Martín Saborido, Carlos hypertension |
title_short |
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults |
title_full |
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults |
title_fullStr |
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults |
title_full_unstemmed |
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults |
title_sort |
Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults |
dc.creator.none.fl_str_mv |
Martín Saborido, Carlos López Alcalde, Jesús Ciapponi, Agustín Sánchez Martín, Carlos Enrique Garcia Garcia, Elena Escobar Aguilar, Gema Palermo, Maria Carolina Baccaro, Fernando G |
author |
Martín Saborido, Carlos |
author_facet |
Martín Saborido, Carlos López Alcalde, Jesús Ciapponi, Agustín Sánchez Martín, Carlos Enrique Garcia Garcia, Elena Escobar Aguilar, Gema Palermo, Maria Carolina Baccaro, Fernando G |
author_role |
author |
author2 |
López Alcalde, Jesús Ciapponi, Agustín Sánchez Martín, Carlos Enrique Garcia Garcia, Elena Escobar Aguilar, Gema Palermo, Maria Carolina Baccaro, Fernando G |
author2_role |
author author author author author author author |
dc.subject.none.fl_str_mv |
hypertension |
topic |
hypertension |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Background: Among people who have suffered a traumatic brain injury, increased intracranial pressure continues to be a major cause of early death; it is estimated that about 11 people per 100 with traumatic brain injury die. Indomethacin (also known as indometacin) is a powerful cerebral vasoconstrictor that can reduce intracranial pressure and, ultimately, restore cerebral perfusion and oxygenation. Thus, indomethacin may improve the recovery of a person with traumatic brain injury. Objectives: To assess the effects of indomethacin for adults with severe traumatic brain injury. Search methods: We ran the searches from inception to 23 August 2019. We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 8) in the Cochrane Library, Ovid MEDLINE, Ovid Embase, CINAHL Plus (EBSCO), four other databases, and clinical trials registries. We also screened reference lists and conference abstracts, and contacted experts in the field. Selection criteria: Our search criteria included randomised controlled trials (RCTs) that compared indomethacin with any control in adults presenting with severe traumatic brain injury associated with elevated intracranial pressure, with no previous decompressive surgery. Data collection and analysis: Two review authors independently decided on the selection of the studies. We followed standard Cochrane methods. Main results: We identified no eligible studies for this review, either completed or ongoing. Authors' conclusions: We found no studies, either completed or ongoing, that assessed the effects of indomethacin in controlling intracranial hypertension secondary to severe traumatic brain injury. Thus, we cannot draw any conclusions about the effects of indomethacin on intracranial pressure, mortality rates, quality of life, disability or adverse effects. This absence of evidence should not be interpreted as evidence of no effect for indomethacin in controlling intracranial hypertension secondary to severe traumatic brain injury. It means that we have not identified eligible research for this review. Fil: Martín Saborido, Carlos. Universidad Nebrija; España Fil: López Alcalde, Jesús. No especifíca; Fil: Ciapponi, Agustín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina Fil: Sánchez Martín, Carlos Enrique. No especifíca; Fil: Garcia Garcia, Elena. Gobierno de la Provincia de Buenos Aires. Hospital Interzonal Especializado de Agudos y Cronicos San Juan de Dios.; Argentina Fil: Escobar Aguilar, Gema. Universidad Nebrija; España Fil: Palermo, Maria Carolina. Universidad de Buenos Aires; Argentina Fil: Baccaro, Fernando G. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina |
description |
Background: Among people who have suffered a traumatic brain injury, increased intracranial pressure continues to be a major cause of early death; it is estimated that about 11 people per 100 with traumatic brain injury die. Indomethacin (also known as indometacin) is a powerful cerebral vasoconstrictor that can reduce intracranial pressure and, ultimately, restore cerebral perfusion and oxygenation. Thus, indomethacin may improve the recovery of a person with traumatic brain injury. Objectives: To assess the effects of indomethacin for adults with severe traumatic brain injury. Search methods: We ran the searches from inception to 23 August 2019. We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 8) in the Cochrane Library, Ovid MEDLINE, Ovid Embase, CINAHL Plus (EBSCO), four other databases, and clinical trials registries. We also screened reference lists and conference abstracts, and contacted experts in the field. Selection criteria: Our search criteria included randomised controlled trials (RCTs) that compared indomethacin with any control in adults presenting with severe traumatic brain injury associated with elevated intracranial pressure, with no previous decompressive surgery. Data collection and analysis: Two review authors independently decided on the selection of the studies. We followed standard Cochrane methods. Main results: We identified no eligible studies for this review, either completed or ongoing. Authors' conclusions: We found no studies, either completed or ongoing, that assessed the effects of indomethacin in controlling intracranial hypertension secondary to severe traumatic brain injury. Thus, we cannot draw any conclusions about the effects of indomethacin on intracranial pressure, mortality rates, quality of life, disability or adverse effects. This absence of evidence should not be interpreted as evidence of no effect for indomethacin in controlling intracranial hypertension secondary to severe traumatic brain injury. It means that we have not identified eligible research for this review. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-11 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/148149 Martín Saborido, Carlos; López Alcalde, Jesús; Ciapponi, Agustín; Sánchez Martín, Carlos Enrique; Garcia Garcia, Elena; et al.; Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults; John Wiley & Sons Ltd; Cochrane Database of Systematic Reviews; 2019; 11; 11-2019; 1-25 1469-493X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/148149 |
identifier_str_mv |
Martín Saborido, Carlos; López Alcalde, Jesús; Ciapponi, Agustín; Sánchez Martín, Carlos Enrique; Garcia Garcia, Elena; et al.; Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults; John Wiley & Sons Ltd; Cochrane Database of Systematic Reviews; 2019; 11; 11-2019; 1-25 1469-493X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://doi.wiley.com/10.1002/14651858.CD011725.pub2 info:eu-repo/semantics/altIdentifier/doi/10.1002/14651858.CD011725.pub2 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
John Wiley & Sons Ltd |
publisher.none.fl_str_mv |
John Wiley & Sons Ltd |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613826224324608 |
score |
13.070432 |